| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns ab...
Wells Fargo analyst Brandon Couillard maintains Danaher (NYSE:DHR) with a Equal-Weight and raises the price target from $205...
Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its full-year...
TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $250 to $260.